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Population and fertility by age and sex for 195 countries and 
territories, 1950–2017: a systematic analysis for the Global 
Burden of Disease Study 2017
GBD 2017 Population and Fertility Collaborators*
Summary
Background Population estimates underpin demographic and epidemiological research and are used to track progress 
on numerous international indicators of health and development. To date, internationally available estimates of 
population and fertility, although useful, have not been produced with transparent and replicable methods and do not 
use standardised estimates of mortality. We present single-calendar year and single-year of age estimates of fertility 
and population by sex with standardised and replicable methods.
Methods We estimated population in 195 locations by single year of age and single calendar year from 1950 to 2017 
with standardised and replicable methods. We based the estimates on the demographic balancing equation, with 
inputs of fertility, mortality, population, and migration data. Fertility data came from 7817 location-years of vital 
registration data, 429 surveys reporting complete birth histories, and 977 surveys and censuses reporting summary 
birth histories. We estimated age-specific fertility rates (ASFRs; the annual number of livebirths to women of a 
specified age group per 1000 women in that age group) by use of spatiotemporal Gaussian process regression and used 
the ASFRs to estimate total fertility rates (TFRs; the average number of children a woman would bear if she survived 
through the end of the reproductive age span [age 10–54 years] and experienced at each age a particular set of ASFRs 
observed in the year of interest). Because of sparse data, fertility at ages 10–14 years and 50–54 years was estimated 
from data on fertility in women aged 15–19 years and 45–49 years, through use of linear regression. Age-specific 
mortality data came from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 estimates. Data 
on population came from 1257 censuses and 761 population registry location-years and were adjusted for 
underenumeration and age misreporting with standard demographic methods. Migration was estimated with the 
GBD Bayesian demographic balancing model, after incorporating information about refugee migration into the model 
prior. Final population estimates used the cohort-component method of population projection, with inputs of fertility, 
mortality, and migration data. Population uncertainty was estimated by use of out-of-sample predictive validity testing. 
With these data, we estimated the trends in population by age and sex and in fertility by age between 1950 and 2017 in 
195 countries and territories.
Findings From 1950 to 2017, TFRs decreased by 49·4% (95% uncertainty interval [UI] 46·4–52·0). The TFR decreased 
from 4·7 livebirths (4·5–4·9) to 2·4 livebirths (2·2–2·5), and the ASFR of mothers aged 10–19 years decreased from 
37 livebirths (34–40) to 22 livebirths (19–24) per 1000 women. Despite reductions in the TFR, the global population 
has been increasing by an average of 83·8 million people per year since 1985. The global population increased by 
197·2% (193·3–200·8) since 1950, from 2·6 billion (2·5–2·6) to 7·6 billion (7·4–7·9) people in 2017; much of this 
increase was in the proportion of the global population in south Asia and sub-Saharan Africa. The global annual rate 
of population growth increased between 1950 and 1964, when it peaked at 2·0%; this rate then remained nearly 
constant until 1970 and then decreased to 1·1% in 2017. Population growth rates in the southeast Asia, east Asia, and 
Oceania GBD super-region decreased from 2·5% in 1963 to 0·7% in 2017, whereas in sub-Saharan Africa, population 
growth rates were almost at the highest reported levels ever in 2017, when they were at 2·7%. The global average age 
increased from 26·6 years in 1950 to 32·1 years in 2017, and the proportion of the population that is of working age 
(age 15–64 years) increased from 59·9% to 65·3%. At the national level, the TFR decreased in all countries and 
territories between 1950 and 2017; in 2017, TFRs ranged from a low of 1·0 livebirths (95% UI 0·9–1·2) in Cyprus to a 
high of 7·1 livebirths (6·8–7·4) in Niger. The TFR under age 25 years (TFU25; number of livebirths expected by age 
25 years for a hypothetical woman who survived the age group and was exposed to current ASFRs) in 2017 ranged 
from 0·08 livebirths (0·07–0·09) in South Korea to 2·4 livebirths (2·2–2·6) in Niger, and the TFR over age 30 years 
(TFO30; number of livebirths expected for a hypothetical woman ageing from 30 to 54 years who survived the age 
group and was exposed to current ASFRs) ranged from a low of 0·3 livebirths (0·3–0·4) in Puerto Rico to a high of 
3·1 livebirths (3·0–3·2) in Niger. TFO30 was higher than TFU25 in 145 countries and territories in 2017. 33 countries 
had a negative population growth rate from 2010 to 2017, most of which were located in central, eastern, and western 
Europe, whereas population growth rates of more than 2·0% were seen in 33 of 46 countries in sub-Saharan Africa. 
In 2017, less than 65% of the national population was of working age in 12 of 34 high-income countries, and less than 
50% of the national population was of working age in Mali, Chad, and Niger.
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Introduction
Age-sex-speciﬁc estimates of population are a bedrock of 
epidemiological and economic analyses, and they are 
integral to planning across several sectors of society. As 
the denominator for most indicators, such estimates 
permeate every aspect of our understanding of health 
and development. Errors in population estimates aﬀect 
national and international target tracking and time-series 
and cross-country analyses of development outcomes. 
The impor tance of accurate population estimates for 
government planning cannot be overstated: population 
size, age, and composition dictate the national need for 
infrastructure, housing, education, employment, health 
care, care of older people, electoral representation, 
provision of public health and services, food supply, and 
security.1 Similarly, fertility rates, both by maternal age 
and overall, are key drivers of population growth and 
important social outcomes in their own right.
Many governments typically produce national popu-
lation estimates by age and sex for planning purposes. 
Most international studies and comparative indicators, 
including the Millennium Development Goals and the 
Sustainable Development Goals, rely on the estimates 
generated by the UN Population Division at the 
Department of Economics and Social Aﬀairs (UNPOP) 
for population denomi nators,2,3 although it is not well 
documented how often these estimates are used by 
national governments. The UNPOP has produced 
population estimates since 1951, and it uses a de-
centralised approach to estimation.4 For example, the 
Latin American and Caribbean Demographic Centre 
produces estimates for Latin America, whereas estimates 
for all other groups of countries are developed by analysts 
in New York. Although the UNPOP describes a general 
approach of examining data on fertility, mortality, 
migration, and population and searching for consistency,5 
replicable statistical methods are not used. Decisions on 
how to deal with inconsistency between the compo-
nents of fertility, mortality, and migration within 
population counts are left to individual analysts, leading 
to considerable hetero geneity in approaches across 
countries. Accordingly, discrepancies between UNPOP 
and nationally produced estimates—for instance, in 
2015, the population estimates for Mexico by UNPOP 
were 4·6 million more than those of Mexico’s National 
Population Council (125·9 million by UNPOP vs 
Interpretation Population trends create demographic dividends and headwinds (ie, economic beneﬁts and detriments) 
that aﬀect national economies and determine national planning needs. Although TFRs are decreasing, the global 
population continues to grow as mortality declines, with diverse patterns at the national level and across age groups. 
To our knowledge, this is the ﬁrst study to provide transparent and replicable estimates of population and fertility, 
which can be used to inform decision making and to monitor progress.
Funding Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Research in context
Evidence before this study
Population estimates by age and sex are extensively used in all 
forms of epidemiological and demographic analysis. National 
estimates of population and fertility for age and sex groups 
have been produced by the UN Population Division since 1951. 
The US Census Bureau produces revised demographic estimates 
for 15 to 30 countries each year. Several national authorities 
produce their own population estimates, particularly those in 
high and middle Socio-demographic Index countries. These 
efforts are all based on the cohort-component method of 
population projection, namely that population in an age group 
at a given time t must equal the population in that cohort at 
the start of the time period (t–1) plus new entrants and minus 
people exiting the population because of migration and death. 
Although these estimates are based on the demographic 
balancing equation, estimates are not based on standardised, 
transparent, or replicable statistical methods.
Added value of this study
To our knowledge, this study presents the first estimates of 
population by location from 1950 to 2017 that are based on 
transparent data and replicable analytical code, applying a 
standardised approach to the estimation of population for each 
single year of age for each calendar year from 1950 to 2017 for 
195 countries and territories and for the globe. This study 
provides improved population estimates that are internally 
consistent with the Global Burden of Diseases, Injuries, and Risk 
Factors Study’s assessment of fertility and mortality, which are 
important inputs to other epidemiological research and 
government planning. 
Implications of all the available evidence
Population counts by age and sex that are produced with a 
transparent and empirical approach will be useful for 
epidemiological and demographic analyses. The production of 
annual estimates will also facilitate timely tracking of progress 
on global indicators, including the Sustainable Development 
Goals. In the future, the methods applied here can be used to 
enhance population estimation at the subnational level. 
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121·3 million by National Population Council)—cannot 
currently be resolved.4,6
The US Census Bureau’s International Division 
periodically releases detailed population analyses for 
selected countries, with new revisions produced for 
15 to 30 countries per year.7 Other organisations, such as 
the Population Reference Bureau,8 the World Bank,9 
the Wittgenstein Centre,10 and Gapminder Foundation11 
also release population estimates, but these are largely 
combinations of national estimates with selected UNPOP 
or US Census Bureau analyses. Many of the organi-
sations who estimate or report on population also 
provide fertility estimates, which, in addition to aﬀecting 
population trends, are used to monitor reproductive 
health service delivery in many locations. To our 
knowledge, global estimates of annual population by age 
and sex with underlying primary data and replicable 
computer code and statistical modelling details are not 
available from any source.
The Global Burden of Diseases, Injuries, and Risk 
Factors Study (GBD) is committed to the Guidelines on 
Accurate and Transparent Health Estimates Reporting 
(GATHER).12 Continued use of the UNPOP population 
estimates in GBD is not compatible with GATHER 
because the methods used for UNPOP estimation are 
not transparent and uncertainty intervals are not 
estimated for populations.4 Moreover, UNPOP population 
esti mates, especially in years between or after a census, 
are inconsistent with GBD estimates because there is a 
marked diﬀerence between UNPOP and GBD estimates 
of age-speciﬁc mortality in many instances.13,14 For this 
GBD 2017 paper, we sought to produce population 
estimates and associated fertility estimates for 
195 countries and territories from 1950 to 2017 that were 
based on the available census or population registry data 
and survey and census data on age-speciﬁc fertility rates 
(ASFR; ie, the annual number of livebirths to women of a 
speciﬁed age group per 1000 women in that age group) 
by use of replicable methods, leveraging the previous 
GBD work that estimated age-sex-speciﬁc mortality 
rates.15 To achieve this goal, we aimed to conduct 
systematic analyses of available sources that could 
inform ASFR estimation and to systematically identify 
and extract census and population registry data.
Methods
Overview
As with all population estimation, the underlying 
equation used for GBD is based on the demographic 
balancing equation16
where N (T) is the population at a given time, N (0) is the 
population at the start of the interval, B (0,T) is livebirths 
during the interval, D (0,T) is deaths during the interval, 
and G (0,T) is net migration during the interval.
The cohort-component method of population pro jection 
extends this demographic balancing equation to estimate 
internally consistent age-sex-speciﬁc popu lations. The 
method requires estimates of ASFRs, sex ratio at birth, 
age-sex-speciﬁc net migration, and age-sex-speciﬁc mor-
tality rates that are consistent with observed population 
counts that have been corrected for underenumeration or 
overenumeration. GBD provides a consistent set of age-
sex-speciﬁc mortality rates with standardised methods;15 in 
this analysis, we estimated the sex ratio at birth, ASFR, and 
age-sex-speciﬁc migration rates consistent with the 
available population data to create a full time series of 
population estimates by age and sex.
These estimates comply with GATHER (appendix 1 
section 5). Analyses were done with R version 3.3.2, Python 
version 2.7.14, or Stata version 13.1. Data and statistical 
code for all analyses are publicly available online. 
Geographical units and time periods
We produced single calendar-year and single year-of-
age population estimates for 195 countries and territories 
that were grouped into 21 regions and seven super-
regions. The seven super-regions are central Europe, 
eastern Europe, and central Asia; high income; 
Latin America and the Caribbean; north Africa and the 
Middle East; south Asia; southeast Asia, east Asia, and 
Oceania; and sub-Saharan Africa. Each year, GBD includes 
sub national analyses for a few new countries and 
continues to provide subnational estimates for countries 
that were added in previous cycles. Subnational estimation 
in GBD 2017 includes ﬁve new countries (Ethiopia, Iran, 
New Zealand, Norway, Russia) and countries previously 
estimated at subnational levels (GBD 2013: China, Mexico, 
and the UK [regional level]; GBD 2015: Brazil, India, 
Japan, Kenya, South Africa, Sweden, and the USA; GBD 
2016: Indonesia and the UK [local government authority 
level]). All analyses are at the ﬁrst level of administrative 
organisation within each country except for New Zealand 
(by Māori ethnicity), Sweden (by Stockholm and non-
Stockholm), and the UK (by local government authorities). 
All subnational estimates for these countries were 
incorporated into model development and evaluation as 
part of GBD 2017. To meet data use requirements, in this 
publication we present all subnational estimates excluding 
those pending publication (Brazil, India, Japan, Kenya, 
Mexico, Sweden, the UK, and the USA); given space 
constraints, these results are presented in appendix 2 
instead of the main text. Subnational estimates for 
countries with populations of more than 200 million 
people (assessed by use of our most recent year of 
published estimates) that have not yet been published 
elsewhere are presented wherever estimates are illus-
trated with maps but are not included in tables. Estimates 
were produced for the years 1950–2017. 1950 was selected 
as the start year for the analysis because we were unable to 
locate suﬃcient data on ASFR, mortality, and population 
before 1950.
N(T)=N(0) + B(0,T) – D(0,T) + G(0,T)
See Online for appendix 1
For the statistical code see 
http://ghdx.healthdata.org/gbd-
2017
See Online for appendix 2
Global Health Metrics
1998 www.thelancet.com   Vol 392   November 10, 2018
Fertility
Fertility data are obtained from vital registration systems, 
complete birth histories, or summary birth histories. 
Complete birth histories include the date of birth and, if 
applicable, the dates of death of all children ever born 
alive to each woman that is interviewed, whereas 
summary birth histories include the total number of 
children ever born alive to each mother and the total 
number of those children born alive to each mother that 
have died. In countries with complete birth registration, 
vital registration systems typically provide tabulations of 
births by age of the mother. From 1890,17 some censuses 
asked about the number of children ever born to a 
woman, and this question has been widely asked in 
censuses and many household surveys in the past 
70 years. From the 1970s, fertility information has also 
been collected through complete birth histories, 
beginning with the World Fertility Survey, then the 
Demographic and Health Surveys, and, in some 
countries, the Multiple Indicator Cluster Surveys, 
sponsored by the UN Children’s Fund. We identiﬁed 
977 censuses and household surveys that had summary 
birth history data, 429 household surveys that had 
complete birth history data, and 7817 country-years of 
birth registration systems through searches of national 
statistical sources and the Demographic Yearbooks 
produced by the UN Statistics Division from 1948 to 
present.18 The number and type of sources for each 
location are provided in appendix 1 (section 5). The 
Global Health Data Exchange provides the metadata for 
all these sources.
Given the hetergeneous nature of the data (vital 
registration, summary birth histories, complete birth 
histories), we used a two-stage approach to modelling the 
ASFR for the age groups 15–19 years, 20–24 years, 
25–29 years, 30–34 years, 35–39 years, 40–44 years, and 
45–49 years. The two-stage approach was designed to take 
advantage of the greater availability of some summary 
birth history data for the period 1950 to 1975 and to help 
to compensate for the lower availability of complete birth 
history data in some low-income countries. For the 
fertility rates in those aged 10–14 years and 50–54 years, 
which are much lower than in other age groups and for 
which only vital registration data were available, we used 
a separate, simpler approach, described later in this 
section.
In the ﬁrst stage of our analysis, we used spatio temporal 
Gaussian process regression to analyse vital registration 
and complete birth history data.15,19 For spatiotemporal 
Gaussian process regression, the prior was estimated 
separately for women aged 20–24 years, with average years 
of schooling in women aged 20–24 years as the covariate. 
For all other age groups, the prior was estimated with a 
spline on the estimated ASFR for women aged 20–24 years 
and with the average years of schooling for the age group 
of interest. The prior for GBD locations in the high-
income super-region did not include average years of 
schooling as a covariate. Spline knots were selected by 
inspection of the data to identify where there was a 
reversal in trend. The purpose of this approach was to 
capture an increase in fertility rates in women aged 
30 years or older while the ASFR for women aged 
20–24 years decreased below a speciﬁc threshold. Given 
that the point of inﬂection for the ASFR for women aged 
30 years or older relative to the ASFR for women 
aged 20–24 years varied by super-region, we ﬁt the models 
separately for some GBD super-regions (high income; 
sub-Saharan Africa; and central Europe, eastern Europe, 
and central Asia) and modelled the rest of the super-
regions together. The ﬁrst step of the model also included 
location-and-source-speciﬁc random eﬀects to correct bias 
from non-sampling error in diﬀerent source types, such 
as incomplete vital registration. Hyperparameters for the 
model were selected on the basis of a measure of data 
density. Further details on this process are provided in 
appendix 1 (section 2).
In the second stage of the analysis, we used the 
ASFR estimates from the ﬁrst stage to process and 
incorporate several forms of aggregated data. First, we 
split cumulative cohort fertility data (ie, children ever 
born) from summary birth history into period ASFR data. 
For this split, we computed the ratio between reported 
children ever born alive from each 5-year cohort of women 
represented in a given data source and the total fertility for 
each of these cohorts that was implied by the ﬁrst-stage 
estimates of ASFR by location and year. This ratio 
was applied as a scaling factor to our estimated cohort 
ASFR at 5-year intervals (when all members of the cohort 
all belong to a single 5-year GBD age group), to distribute 
experienced fertility (ie, from age 10 years until the date of 
the survey in women interviewed from the cohorts 
speciﬁed in the original data) back across age and time. 
Additionally, we used the estimated age proportion of 
livebirths from the ﬁrst stage to distribute total reported 
livebirths by the age of the mother. Lastly, for historical 
location aggregates for which we had registry data (eg, the 
Soviet Union), we used the estimated proportions of age-
speciﬁc livebirths in constituent locations from the ﬁrst 
stage to allocate births back in time to their current 
GBD geographies. This new set of methods allowed us to 
supplement the model with a substantial amount of 
additional information about the overall fertility. We then 
re-estimated ASFR as described, with all vital registration, 
complete birth history, and split data to produce ﬁnal 
fertility estimates for women aged 15–49 years.
In both the ﬁrst and second stage, data were adjusted in 
the mixed-eﬀects model on the basis of random 
eﬀects values (appendix 1 section 2) by selecting a 
reference or benchmark source. In locations with 
complete child death registration (see previous GBD 
analyses),15,20 vital registration was typically the benchmark 
or reference source. In other locations, Demographic and 
Health Survey complete birth history data were used as 
the reference source. If neither vital registration nor 
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Demographic and Health Survey complete birth histories 
were available, other complete birth history sources were 
used as the reference. If no vital registration or complete 
birth history data were used, then the average of all 
remaining summary birth history sources were used as 
reference. Where sources were inconsistent or 
implausible time trends were identiﬁed, some reference 
source designations were modiﬁed; the ﬁnal choice of 
reference sources for each location are provided in the 
appendix 1 (section 5).
Many household surveys on fertility excluded women in 
the age groups 10–14 years and 50–54 years, and 
these data were limited to 3947 country-years of vital 
registration data. To estimate fertility in girls aged 
10–14 years, we used a linear regression of the log of the 
ratio of the ASFR of girls aged 10–14 years to the ASFR for 
girls aged 15–19 years as a function of the ASFR for girls 
aged 15–19 years. For women aged 50–54 years, we found 
no covariates that predicted variation in the ratio of ASFR 
for women aged 50–54 years to the ASFR for those aged 
45–49 years. In this case, we assumed the ratio of ASFR 
for women aged 50–54 years to ASFR for women aged 
45–49 years was constant across locations and over time.
Our analysis generated a full set of ASFRs for each 
location and year from 1950 to 2017; we used these ASFRs 
to compute the total fertility rate (TFR), which is the 
average number of children a woman would bear if she 
survived through the end of the reproductive age span 
(age 10–54 years) and experienced at each age a particular 
set of ASFRs observed in the year of interest. We also 
estimated the total fertility rate under age 25 years 
(TFU25; number of livebirths expected by age 25 years for 
a hypothetical woman who survived the age group and 
was exposed to current ASFRs) and the total fertility in 
women older than 30 years (TFO30; number of livebirths 
expected for a hypothetical woman ageing from 30 to 
54 years who survived the age group and was exposed to 
current ASFRs). These age ranges were computed 
because nearly all locations show decreases in the TFU25 
over time, with few or no reversals. In women aged 30 
years or older, there is a clear U-shaped curve, with 
decreases followed by sustained increases; in women 
aged 25–29 years, the pattern is less consistent. The 
fertility rate in girls aged 10–19 years is a Sustainable 
Development Goal (SDG) indicator for goal 3, target 3.7: 
ensure universal access to sexual and reproductive health-
care services, including for family planning, information 
and education, and the integration of reproductive health 
into national strategies and programmes.21
We estimated the sex ratio at birth with 4690 unique 
location-years of registered livebirths by sex, 1756 location-
years of census and population registry counts that 
included children younger than 1 year and younger than 
5 years by sex, and 2490 location-years of the proportion 
of live-born males from complete birth history. These 
data informed a spatiotemporal Gaussian process 
regression model of the proportion of live-born males, 
assuming a time-invariant prior for the mean because, in 
the absence of sex-selective abortion, we would not expect 
the sex ratio at birth to deviate signiﬁcantly from its 
natural equili brium. Hyperparameters for spatiotemporal 
smoothing and Gaussian process regression were chosen 
on the basis of data-density scores, taking into account 
both the quantity and quality of available data. Our 
analysis only produced national estimates of sex ratio at 
birth—including for Hong Kong and Macau—for all 
years from 1950 to 2017; thus, we assume that subnational 
sex ratio at birth equals the national sex ratio at birth. 
With additional data seeking and extraction, we will 
extend the analysis to all GBD locations in the next GBD 
study. Further details regarding sex ratio at birth 
estimation are shown in appendix 1 (section 2).
Population
To determine national and subnational populations, we 
searched the Integrated Public Use Microdata Series 
questionnaires, the UN Demographic Yearbook, the UN 
census programme census dates, and the International 
Population Census Biography to identify all censuses 
conducted between 1950 and 2017 and available popu-
lation registers.22–25 We included 1233 censuses and 
26 population registers that contained 730 location-years 
of census or population registry data. In some cases, 
the same census was reported by diﬀerent sources 
in diﬀerent years. We resolved these incon sistencies 
through a review of available documentation. A list of 
all conﬁrmed censuses is shown in the appendix 1 
(section 5). We obtained population counts that were age-
sex-speciﬁc from 1171 censuses and only by sex from 
62 censuses. We sought to identify whether the counts in 
each census were de facto (allocated to the place of 
enumeration) or de jure (allocated to the place of regular 
or legal residence). Our basis for population estimation 
is the de-facto population and, where both counts were 
available, we used de-facto counts. Where only de-jure 
counts were available—typically in lower Socio-
demographic Index (SDI) countries—we assumed that 
de-jure and de-facto populations were similar. The main 
diﬀerence between the counts at the national level is the 
exclusion of some migrant workers in some de-jure 
counts; where migrant workers are known to be an 
important fraction of the population and de-facto counts 
were not available, we searched directly for data on 
documented migration.
In several cases, the UN does not recognise admin-
istrative splits in territories, including Kosovo and 
Serbia, Transnistria and Moldova, and the so-called 
Turkish Republic of Northern Cyprus and Cyprus.26 
In these cases, we obtained census counts for the 
components and interpolated to generate census counts 
for the full territory. For east and west Germany before 
uniﬁcation, as the input to the model, we used census 
counts for each component and interpolation to 
generate estimates of joint census counts in years 
Global Health Metrics
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closest to the censuses in both locations. We were able 
to obtain census counts for ﬁve of the six constituent 
components that made up Yugoslavia; for Serbia we 
split aggregate Yugoslavia census data with previous 
population estimates. For Singapore, we estimated the 
population for residents and non-resident workers 
combined (appendix 1 section 2). Of the 1963 location-
years of census or population registry data, 
72 lo cation-years were identiﬁed as outliers that were 
inconsistent with adjacent data, model analysis, or 
excluded subpopulations.
Census counts are typically undercounts of the actual 
population, although there are known cases in which 
censuses have overcounted the population.27–29 Post-
enumeration surveys (PESs) aim to identify instances of 
overcounts or undercounts by comparing data. Many, if 
not most, PESs are not published or are only reported in 
government releases, presentations, or online reports. 
PESs themselves are subject to considerable error, whether 
they use a direct or indirect method of estimating census 
completeness. We searched for all available PES results 
and supple mented these results with publications or 
presentations that provided summaries of other PESs.30–34 
We identiﬁed 165 PESs, although it is likely that many 
more were done that did not publicly report their results. 
We analysed the 165 PESs to generate a general model of 
census com pleteness as a function of SDI. Because of 
variable quality of PESs, we assumed that, in aggregate, 
the 165 PESs provided an unbiased view of the association 
between enumeration completeness and SDI, so we 
adjusted census counts by the predictions from this model. 
We used nationally reported PES results to adjust census 
counts in high SDI countries and used the estimated 
census completeness to adjust data in other settings. 
To account for systematic age variation in census 
enumeration, we input age-sex-speciﬁc PES results into 
DisMod-MR 2.1, a Bayesian meta-regression tool, to 
estimate a global age pattern of enumeration. This age 
pattern was then used to adjust the overall predicted 
enumeration to vary by age (appendix 1 section 2).
As has been extensively noted in the demographic 
literature, census counts have several common problems: 
undercounts (particularly of children younger than 
5 years), a tendency to exaggerate age at older ages, and 
age heaping (reporting ages rounded to the nearest 
5 or 10 years).35–38 The population counts from 
four diﬀerent censuses, illustrating the diﬀerent types of 
age heaping and undercounts, are shown in ﬁgure 1. We 
evaluated the age structure and consistency of census 
data by calculating sex and age ratios for each census. 
These ratios were then used to calculate sex and age ratio 
scores, which were combined into a joint score. The joint 
score was used to determine whether to apply a correction 
to the census counts or not. For census counts available 
in 1-year age groups, we used the Feeney correction; 
for counts available in 5-year or 10-year age groups, we 
used either the Arriaga or Arriaga strong correction.39,40 
More details on the age-heaping corrections are shown in 
appendix 1 (section 2). For all censuses in low and middle 
SDI countries, we did not use the census count of 
children younger than 5 years in our model estimation. 
In other words, population estimates in these age groups 
were driven by fertility and mortality estimates and 
consistency with the later census counts for the same 
cohort. Systematic over estimation of age, particularly in 
some countries in sub-Saharan Africa and Latin America, 
was apparent in the data; for example, census counts 
could only be explained by large immigration of 
populations at older ages, which appears implausible. 
We were unable to correct the data for these issues and 
used the modelling strategy that is subsequently 
described to deal with these challenges.
Our approach requires an estimate of the population 
in 1950 in all locations for detailed age and sex groups; 
only 54 countries had a census count in 1950. For 
most other locations, we used backwards application of 
the cohort-component method of population projection by 
use of the oldest available census and the reverse 
application of estimated mortality rates and an assumption 
of zero net migration (appendix 1 section 2). As sub-
sequently noted, in our GBD Bayesian demographic 
balancing modelling framework, the base line population 
is assumed to be measured with substantial error, and 
the model produced posterior estimates that varied 
considerably from this initial baseline.
We used the estimates of population by location and 
year for each single year of age to generate other 
summary measures, including population growth rates 
that assumed logarithmic growth and the proportion 
of the population that was of working age, which is 
deﬁned by the Organisation for Economic Co-operation 
and Development and the World Bank as those aged 
15–64 years.41,42
Mortality
The GBD mortality process produced annual abridged life 
tables that comprised 24 age groups: younger than 1 year, 
1–4 years, and then 5-year age groups up to age 110 years 
or older.13 To project populations forwards in time with the 
cohort-component method of population projection, we 
needed annual period life tables with single-year age 
groups up to 95 years or older. For ages 15–99 years, we 
interpolated abridged l
x
 values (the number of people still 
alive at age x for a hypothetical cohort in a period life table) 
by use of a monotone cubic spline with Hyman ﬁltering.43,44 
For people younger than 15 years and older than 100 years, 
we applied regression coeﬃ cients to predict single-year 
age group probability of death values. The Human 
Mortality Database provided 4557 empirical full-period life 
tables for 48 locations. We excluded 1280 of the life tables 
because they were identiﬁed by the Human Mortality 
Database as proble matic or occurred during time periods 
with extremely high mortality, such as World War 2 or 
the 1918 inﬂuenza pandemic. To predict probability of 
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death qx at age x for single-year age groups, we ﬁt the 
following separate linear regression by single-year age 
group between ages zero and 110: 
where 1qxf is the single-year age group qx value from the full-
period life table, β0 is the coeﬃcient for the intercept, β1 is 
the coeﬃcient for the slope, εxf is the error term, and 5qxa is 
the correponding abridged life-table age group’s qx value. 
These predicted 1qxf values were scaled to the GBD abridged 
life-table 5qx values for consis tency. 
For those aged 15–99 years, the non-parametric spline 
approach did not require rescaling to match the abridged 
5qx values and, consequently, produced smooth steps 
in mortality across single-year ages and between 5-year 
age groups. The regression coeﬃcients were applied to 
children younger than 15 years because of the unique 
patterns of single-year mortality younger than 15 years 
and to adults older than 100 years because of instability 
caused by low lx values at older ages. To mitigate instability 
caused by spikes in mortality due to fatal discontinuities 
such as wars and natural disasters, full-period life tables 
were ﬁrst generated based on abridged life tables without 
fatal discontinuities, and then fatal discontinuities were 
added to nmx (the death rate in age group x to x + 1 for a 
hypothetical cohort in a period life table) assuming a 
constant death rate for fatal discontinuities within each 
age group. To produce full life tables with the complete 
set of single-year age group 1qx values, we assumed 1ax (the 
average number of years lived in age group x to x + 1 by 
people who died during the interval for a hypothetical 
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Figure 1: Census age patterns for females in 1970 in the USA (A), males in 2001 in Bangladesh (B), females in 1979 in Afghanistan (C), and males in 2010 in Russia (D)
Lines show the model posterior and datapoints. Data processing steps are indicated by symbols. The 95% uncertainty interval is shown by light blue shading around the model posterior. 
PES=post-enumeration survey.
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cohort in a period life table) was 0·5 in all age groups 
except for those younger than 1 year and older than 
110 years; these groups were assumed to be identical to 
the abridged life-table 1ax values.
Migration
Real data on age-speciﬁc net migration are more diﬃcult 
to obtain than data on fertility, population, and mortality. 
Net migration includes any change in the de-facto 
population that is not accounted for by births or deaths; 
this number would include refugees and temporary 
workers. For most country-years, documented net 
migration data are not reported and undocumented net 
migration is not estimated. For some high-SDI countries, 
net migration is tracked and reported,45 and the UN High 
Commission for Refugees (UNHCR) reports the stock of 
refugees (the count of people not born in the country that 
they currently live in) in each country by country of origin 
at the end of year. In more recent census rounds, census 
questions on the number of foreign-born individuals 
living in a country have been used, as have assumptions 
on diﬀerential survival to estimate when migration 
occurred;46 however, these approaches, especially for the 
period before 2000, have considerable uncertainty 
associated with them and are heavily dependent on 
fertility and mortality assum ptions for migrants.
We developed and applied the GBD Bayesian demo-
graphic balancing model to estimate net migration by 
single year of age and single calendar year, consistent 
with our estimates of age-sex-speciﬁc mortality and 
ASFR and the observed population data. Our model was 
developed on the basis of the work of Wheldon and 
colleagues47–49 but includes important modiﬁcations, such 
as correlation of migration rates across ages and over 
time and single-year, single-age estimation. Details on 
our GBD Bayesian demographic balancing model, 
developed in Template Model Builder, an open-source 
statistical package for R,50 are shown in the appendix 1 
(section 2).
In applying the model, we dealt with known issues of 
age misreporting by including larger input data variance 
for population counts at the youngest ages and input 
variance that steadily increases after age 45 years. The 
choice of data variance was based on testing of a range of 
variance assumptions; variance assumptions only change 
the point estimates of the results in settings where there 
is substantial inconsistency between adjacent census 
counts or between census counts (or both) and in the 
key inputs. To address age misreporting in the oldest 
ages, we ran several model versions for each location. For 
each model version, we excluded census counts above a 
given maximum age from the model ﬁtting process 
(appendix 1 section 5). We then selected the best model 
version by prioritising versions that used the highest 
maximum age, predicted low absolute values of migration 
in the age groups older than 55 years, and had good 
in-sample ﬁts. In high-income locations, the selection 
algorithm often chose the model version that did not 
exclude any of the census data for older ages but, in other 
regions, the population estimates at older ages were 
driven by the census counts for younger ages and the 
mortality estimates that aged those people forwards in 
time (appendix 1 section 2).
An example of the ﬁt to the available population data for 
the eight largest populations in 2017 is shown in ﬁgure 2. 
Overall, the in-sample ﬁt of the model for age-sex-speciﬁc 
population log space had an R² value of 0·99. These ﬁts 
show that the model closely tracks the available corrected 
census counts for all ages combined and by age. Code 
for the GBD Bayesian demographic balancing model 
is available at the Global Health Data Exchange. The 
population estimates and census and registry data for all 
195 countries and territories are shown in appendix 2.
The cohort-component method of population 
projection and uncertainty
We produced ﬁnal population estimates by single year and 
by single-year age groups with the cohort-component 
method of population projection.16 The population in 
each single-year age group in each year was estimated 
on the basis of the estimated starting population and 
single-year, single-age rates of migration, fertility, and 
mortality. Uncertainty in population estimates comes 
from two fundamental sources: uncertainty about the 
complete ness of a census count in a census year and 
uncertainty between censuses due to errors in estimates 
of migration, fertility, and mortality. Uncertainty in the 
counts was estimated by sampling the variance-covariance 
matrix of the model that predicted census completeness. 
We estimated the uncertainty between counts by use 
of out-of-sample predictive validity. We held out data 
and estimated the error in estimates as a function of 
the minimum of the number of years to the next 
or previous census. We combined these two sources of 
uncertainty and generated 1000 draws of percentage error 
in the population for each location-year. The 1000 draws of 
percentage error in the population and the population 
mean, generated by the GBD Bayesian demographic 
balancing model, were then combined to create 1000 draws 
of population by age, sex, location, and year. 95% uncer-
tainty intervals (UIs) were calculated with the 2·5th and 
97·5th percentiles. Details of this out-of-sample estimation 
of uncertainty are shown in appendix 1 (section 2). Out-of-
sample estimates of uncertainty yielded larger uncertainty 
than in-sample methods because of the nearly perfect 
inverse correlation between migration and death rates, 
which was conditional on census counts with low error. 
A dot plot comparison of our total population counts by 
country for diﬀerent age groups in 2017 with UNPOP 
estimates is shown in appendix 2.
SDI
GBD 2015 developed the SDI as a composite measure of 
TFR in a population, lag-distributed income per capita, 
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Figure 2: Fit of the GBD Bayesian demographic balancing model for the total population of males and females, from 1950 to 2017, in mainland China (A), India (B), the USA (C), Indonesia (D), 
Pakistan (E), Brazil (F), Nigeria (G), and Bangladesh (H)
The 95% uncertainty interval is shown by light blue shading around the model posterior line. Mainland China excludes Hong Kong and Macao. GBD=Global Burden of Diseases, Injuries, and Risk Factors 
Study.
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and average years of education in the population older 
than 15 years.15,20 Each component was rescaled to a value 
between 0 and 1, and the SDI was derived from their 
geometric mean. The TFR was used in this overall 
measure of development as a proxy for the status of 
women in society; other plausible measures capturing 
the status of women are not available for all countries 
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Figure 3: Global total fertility rate distributed by maternal age group (A) and number of livebirths by GBD super-region, for both sexes combined (B), 1950–2017
Total fertility rate is the number of births expected per woman in each age group if she were to survive through the reproductive years (10–54 years) under the age-specific fertility rates at that 
timepoint. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
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revealed in many countries that, through the process of 
development the TFO30 generally decreased and then 
increased. For example, in the USA, the TFO30 has 
increased steadily from 1975. In exploratory analysis, we 
found that the TFU25 did not show this U-shaped pattern 
as countries develop. For GBD 2017, we have recalculated 
the SDI by use of the TFU25 as a better proxy for the 
status of women in society. The TFU25 not only does 
not show a U-shaped pattern with development but 
also remains highly correlated with under-5 mortality 
(Pearson correlation coeﬃcient r=0·873) and other 
mortality measures. The revised method for computing 
SDI compared with the GBD 2016 method is correlated 
with the GBD 2017 method (r=0·992). Detailed 
comparisons of the GBD 2015 and GBD 2016 methods 
compared with the approach we used are shown in 
appendix 1 (section 3).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. All authors had full access to all the data in the 




The global TFR by maternal age group from 1950 to 2017 
is shown in ﬁgure 3. In 1950, the TFR was 4·7 livebirths 
(95% UI 4·5–4·9) and, by 2017, the TFR had decreased by 
49·4% (46·4–52·0) to 2·4 livebirths (2·2–2·5). From 1950 
to 1995, the TFR within all 5-year maternal age groups 
decreased: the greatest decrease in terms of contribution 
to TFR was in women aged 20–24 years (who showed a 
decrease of 0·42 livebirths), 25–29 years (0·52 livebirths), 
and 30–34 years (0·38 livebirths). Since 1995, decreases in 
the contribution to TFR from women aged 30–34 years, 
35–39 years, and 40–44 years eﬀectively plateaued at the 
global level, whereas decreases in women at younger ages 
continued. This slowing trend in reductions in the 
number of livebirths per woman in these age groups 
masks marked heterogeneity across countries, as we 
subsequently discuss. Of the total livebirths globally in 
2017, 9·4% occurred in teenage mothers, which is a 
reduction from 9·9% of livebirths to teenage mothers in 
1950. The age-speciﬁc fertility rate per 1000 women aged 
10–19 years decreased from 37 livebirths (34–40) per 
1000 women in 1950 to 22 livebirths (19–24) per 1000 
women in 2017. The number of livebirths globally 
increased from 92·6 million livebirths (88·9–96·4 
million) in 1950 to a peak of 141·7 million livebirths 
(135·8–147·3 million) in 2012. Over the past 35 years, the 
number of livebirths annually has varied within a 
relatively narrow range of 133·2 million (130·1–136·2) 
livebirths to 141·7 million (135·8–147·3) livebirths.
The trend in world population from 1950 to 2017 by 
GBD super-region is shown in ﬁgure 4. From 1950 to 
1980, the global population increased exponentially at an 
annualised rate of 1·9% (95% UI 1·88–1·92). From 
1981 to 2017, however, the pace of the global popu-
lation increase has been largely linear, increasing by 
83·6 million (79·8–87·5) people per year. Over the past 
10 years (2007–17), the average annual increase in 
population has been by 87·2 million (80·8–93·2) people, 
compared with 81·5 million (79·0–84·5) people per year 
in the previous 10 years (1997–2007). The global 
population increased by 197·2% (95% UI 193·3–200·8), 
from 2·6 billion (2·5–2·6) people in 1950 to 7·6 billion 
(7·4–7·9) people in 2017. Over this period, the 
composition of the world’s population changed 
substantially. In 1950, the high-income, central Europe, 
eastern Europe, and central Asia GBD super-regions 
accounted for 35·2% of the global population but, in 
2017, the populations of these countries accounted for 
19·5% of the global population. Large increases occurred 
in the proportion of the world’s population living in 
south Asia, sub-Saharan Africa, Latin America and 
the Caribbean, and north Africa and the Middle East.
The annual population growth rate between 1950 and 
2017, globally and for the GBD super-regions, is shown 
in ﬁgure 4. Growth of the global population increased 
in the 1950s and reached 2·0% per year in 1964, then 
slowly decreased to 1·1% in 2017. The slow shift in the 
global population growth rate is determined by 
markedly diﬀerent trends by super-region. Growth of 
the popu lation in north Africa and the Middle East 
increased until the 1970s, and it has remained quite 
high, at 1·7% in 2017. Population growth rates in sub-
Saharan Africa increased from 1950 to 1985, decreased 
during 1985–1993, increased again until 1997, and then 
plateaued; at 2·7% in 2017, population growth rates 
were almost the highest rates ever recorded in this 
region. The most substantial changes to population 
growth rates were in the southeast Asia, east Asia, and 
Oceania super-region, where the population growth 
rate decreased from 2·5% in 1963 to 0·7% in 2017. The 
large reduction in the population growth rate for this 
super-region around 1960 was due to the Great Leap 
Forward in China. In central Europe, eastern Europe, 
and central Asia, the population growth rate dropped 
rapidly after 1987 and was negative from 1993 to 2008. 
Growth rates in the high-income super-region have 
changed the least, starting at 1·2% in 1950 and reaching 
0·4% in 2017.
Global population pyramids in 1950, 1975, 2000, and 
2017 are shown in ﬁgure 5. As the world’s population 
has grown, not only has the distribution of the global 
population shifted toward sub-Saharan Africa and 
south Asia, but the age structure of the global population 
has also changed considerably. In 1950, the global mean 
age of a person was 26·6 years, decreasing to 26·0 years, 
in 1975, then increasing to 29·0 years in 2000 and 
32·1 years in 2017. Demographic change has economic 
consequences, and the proportion of the population that 
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is of working age (15–64 years) decreased from 59·9% in 
1950 to 57·1% in 1975, then increased to 62·9% in 2000 
and 65·3% in 2017. Another dimension of the global 
population is the proportion of the population that is 
female, which decreased from 50·1% to 49·8% over the 
67-year period.
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Figure 4: Proportion of the global population accounted for by the GBD super-regions (A) and the annual population growth rates, globally and for the super-regions (B)
Data are shown for both sexes combined, from 1950 to 2017. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
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National
Fertility rates vary substantially across countries and 
over time (table 1; appendix 2). In 1950, TFR ranged 
from a low of 1·7 livebirths (95% UI 1·4–2·0) in Andorra 
to a high of 8·9 livebirths (8·7–9·0) in Jordan. The TFR 
decreased in all 195 countries and territories between 
1950 and 2017, and 102 countries and territories showed 
a decrease of more than 50%. By 2017, the TFR ranged 
from a low of 1·0 livebirths (0·9–1·2) in Cyprus to a 
high of 7·1 livebirths (6·8–7·4) in Niger. Although a 
useful summary, the TFR masks variation in trends in 
fertility at diﬀerent ages in many countries. The global 
decrease in median ASFRs from 1950 to 2017 was 
43·4% in women aged 15–19 years and 49·4% in women 
aged 20–24 years, which contrasts with the observed 
decreases in the median ASFR in older age groups of 
mothers of 59·4% in women aged 40–44 years, 65·6% in 
women aged 45–49 years, and 68·7% in women aged 
50–54 years.
In 2017, the TFU25 ranged from 0·08 livebirths 
(95% UI 0·07–0·09) in South Korea to 2·4 livebirths 
(2·2–2·6) in Niger (ﬁgure 6), which is 31 times higher. 
Countries and territories where the TFU25 was 
less than 0·25 livebirths included many in western 
Europe, Japan, South Korea, and Taiwan (province of 
China). TFU25 exceeded 1·5 livebirths in many parts 
of western, eastern, and central sub-Saharan Africa and 
in Afghanistan. Trends in TFO30 are more complex; 
decreases in fertility rate are observed at earlier stages of 
development, and there are sustained increases in 
fertility rate at higher levels of development due to 
women delaying childbearing. TFO30 ranged from a 
low of 0·3 livebirths (0·3–0·4) in Puerto Rico to a high 
of 3·1 livebirths (3·0–3·2) in Niger. In 2017, 145 countries 
showed higher fertility in women older than 30 years 
than in women younger than 25 years. The geographical 
pattern shows low fertility in women older than 30 years 
in disparate settings: central and eastern Europe, China, 
India, many parts of Latin America, and in some parts 
of the Middle East. North America, western Europe, 
central Europe, eastern Europe, Australasia, and high-
income Asia Paciﬁc had a higher TFO30 in 2017 than 
in 1975, with a mean of 60·2% higher TFO30 in 
these regions.
Figure 7 shows the areas where the TFO30 has 







































Figure 5: Global population pyramids for females and males by age, in 1950, 1975, 2000, and 2017
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50% have been observed in most of western Europe, 
high-income North America, Australasia, and high-
income Asia Paciﬁc. The correlation of the ASFR over 
maternal age groups is shown in appendix 2. In 2017, 
169 countries had a sex ratio of less than 1·07 males 
per female at birth. Countries with higher sex ratios at 
birth varied geographically (ﬁgure 7). For example, 
Greenland, Tunisia, and Afghanistan had sex ratios 
between 1·07 and 1·10 males per female at birth, and 
India had a sex ratio at birth of 1·10 males per female. 
Three countries had higher sex ratios at birth: Armenia 
(1·14 males per female), Azerbaijan (1·15 males per 
female), and China (1·17 males per female). High sex 
ratios at birth lower the eﬀective net reproductive rate 
(the number of female livebirths expected per woman, 
given observed age-speciﬁc death and fertility rates) 
even more than the TFR. Estimates of the net 
reproductive rate are shown in table 1. Net reproductive 
rate in 2017 ranged from 0·48 female livebirths 
(0·42–0·56) expected per woman in Cyprus to 
3·00 female livebirths (2·90–3·10) expected per woman 
in Niger. 95 countries had a net reproductive rate of less 
than 1 meaning that, without changes in fertility, death 
rates, or net immigration, populations in those 
countries will eventually decrease.
The population growth rate from 2010 to 2017 is shown 
in ﬁgure 8. 33 countries had a negative population 
growth rate, most of which were located in central, 
eastern, and western Europe and the Caribbean. 
Outside Europe, negative growth rates were observed 
in 14 countries, and the largest negative growth rates 
were observed in Syria, the Northern Mariana Islands, 
Georgia, Puerto Rico, and the Virgin Islands. Cyprus 
(which has a growth rate of 1·7%), Israel (1·9%), and 
Luxembourg (2·3%) are notable in the GBD western 
Europe region because they are the only countries with a 
growth rate greater than 1·2%. Population growth rates 
in North America, Latin America, and the Caribbean 
ranged from –0·5% in Puerto Rico to 2·6% in Belize. 
Population growth rates of more than 2·0% were 
seen in 33 of 46 countries in sub-Saharan Africa. 
The Persian Gulf states, with the exception of the 
United Arab Emirates, all had growth rates of more than 
2·2%, mostly due to the migration of workers, not 
fertility rates. Australia is of note among the GBD 
high-income super-region in the southern hemisphere, 
with a high population growth rate of 1·5%.
Even when countries have a TFR of less than the 
replacement value (the TFR at which a population 
replaces itself from generation to generation, assuming 
no migration; generally estimated to be 2·05),51 popu-
lations can continue to grow because of population 
momentum: the phenomenon by which the past growth 
of birth cohorts leads to more women of childbearing 
age and increased births relative to deaths, even though 
the TFR for a time period is less than the replacement 
value.52 Populations can also grow due to immigration, 
as observed in many Persian Gulf nations. A comparison 
of the 2017 population growth rate versus the TFR is 
shown in ﬁgure 9, which highlights countries in which 
the TFR is less than the replacement value but where 
the population is still growing. The countries where the 
population is declining are also shown. Countries fall 
into four quadrants, deﬁned as a TFR of more than 
or less than the replacement value and a population 
growth rate of more than or less than zero. Divergence 
between these two measures, as noted, is a function of 
lags between period TFR and growth rate (population 
momentum) or net migration.
Population estimates by country since 1950 are shown 
in table 2. Age-sex-speciﬁc detail for these same years is 
provided in appendix 2. Single-year, single-age population 
estimates for the entire period of 1950–2017 are available 
from the Global Health Data Exchange.
The proportion of the population that was of working 
age from 1950 to 2017 by GBD super-region is shown in 
ﬁgure 10. Studies of economic growth have identiﬁed 
the potential for a demographic dividend when the 
proportion of the population that is of working age 
reaches more than 65%.53 In high-income countries, the 
proportion of the population that is of working age 
increased from the 1960s, crossed the 65% threshold in 
the late 1970s, and was relatively constant during 
the 1980s and 1990s. In 2005, this proportion began to 
decrease and was only just more than the 65% threshold 
in 2017. 12 of 34 high-income countries now have a 
proportion of the population of working age that is less 
than 65%, and Japan has a working-age proportion of 
less than 60%. Other than sub-Saharan Africa and high-
income countries, the GBD super-regions have had a 
substantially increasing proportion of the population of 
working age from the mid-1960s to the present day; in 
2017, Latin American and the Caribbean, north Africa 
and the Middle East, south Asia, and central Europe, 
eastern Europe, and central Asia all had proportions of 
the population that are of working age between 64% and 
71%. The most pronounced increase in the working-age 
population occurred in southeast Asia, east Asia, and 
Oceania, which increased from 54·2% of the population 
in 1965 to 72·2% in 2011. Sub-Saharan Africa is the clear 
outlier among GBD super-regions; the proportion of the 
population of working age in this region has remained 
at or less than 55% during the entire time period, 
although this proportion has more recently increased. 
In sub-Saharan Africa, the proportion of the population 
that is of working age was less than 50% in Mali 
(49·7%), Chad (46·6%), and Niger (46·1%) in 2017.
Discussion
Main findings
To our knowledge, this study presents the ﬁrst estimates 
of population by location from 1950 to 2017 that are 
based on transparent data and replicable analytical 
code. Annual population estimates are provided for 
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single calendar years and single-year age groups 
compared with previous assessments that reported 
results for 5-year age groups.4 The global population 
increased nearly three-fold between 1950 and 2017, from 
2·6 billion (2·5–2·6) people in 1950 to 7·6 billion 
(7·4–7·9) people in 2017. Although global popu lation 
growth rates have declined from a peak of 2·0% in 1964 
to 1·1% in 2017, the size of the global population has 
steadily been increasing by more than 80 million people 
annually since 1985. These global estimates mask huge 
country variation, with 35 countries showing decreasing 
populations in 2017 whereas 57 countries had population 
growth at a rate higher than 2·0%. Country variation in 
population growth rates is driven to a large extent by 
wide variations in fertility rates and to a lesser extent by 
migration rates.
Of the 59 countries with a TFR of more than 
three livebirths per woman in 2017 (figure 9), 41 are in 
sub-Saharan Africa. Of the remainder, six countries are 
in north Africa and the Middle East. These continuous 
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95% uncertainty intervals are in parentheses. Data are presented to the number of decimal places as accuracy of these data allows. Super-regions, regions, and countries are listed alphabetically. Total fertility rate is 
the number of livebirths expected per woman in each age group if she were to survive through the reproductive years (10–54 years) under the age-specific fertility rates at that timepoint. Net reproductive rate is 
the number of female livebirths expected per woman, given the observed age-specific mortality and fertility rates. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study. SDI=Socio-demographic Index.
Table 1: Age-specific fertility rates, total fertility rate, total fertility up to a maternal age of 25 years and during ages 30–54 years; the number of livebirths; and net reproductive rate, 
globally and for the SDI groups, GBD regions, super-regions, countries, and territories, 2017
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Figure 6: Total fertility rates under age 25 years (A) and total fertility rate over age 30 years (B), in 2017, by location
Data are the number of livebirths expected for a hypothetical woman by age 25 years (A) or ageing from 30 to 54 years (B) who survived the age group and was exposed to current ASFRs. ATG=Antigua 
and Barbuda. FSM=Federated States of Micronesia. Isl=Islands. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.
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Ratio of males to females at birth
Figure 7: Percentage change in total fertility rates from 1975 to 2017 for women aged 30–54 years (A) and sex ratio at birth in 2017 (B), by location
Data are the number of livebirths expected for a hypothetical woman ageing from 30 to 54 years who survived the age group and was exposed to current age-specific fertility rates (A) and the ratio of males 
to females at birth (B). ATG=Antigua and Barbuda. FSM=Federated States of Micronesia. Isl=Islands. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.
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Figure 8: Population growth rate from 2010 to 2017, by location






























1 2 3 4 5 6 7
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South Asia Southeast Asia, east Asia, and Oceania Sub-Saharan Africa
Figure 9: Relationship between total fertility rates and the population growth rate, 2017
Total fertility rate is the average number of children a woman would bear if she survived through the end of the reproductive age span (age 10–54 years) and experienced at each age a particular set of 
age-specific fertility rates observed in the year of interest. Each dot represents a single country or territory. A vertical line is shown at the total fertility rate of 2·05, representing the replacement value, 
and a horizontal line is shown at a population growth rate of zero. 
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1950 1960 1970 1980 1990 2000 2010 2017
Global 2 571 129 
(2 518 739–
2 623 555)
3 097 198 
(3 016 341–
3 175 666)
3 775 519 
(3 666 324–
3 878 482)
4 546 838 
(4 435 753–
4 651 568)
5 394 707 
(5 276 054–
5 506 245)
6 189 102 
(6 054 565–
6 317 018)
7 032 925 
(6 888 938–
7 176 044)
7 640 466 
(7 394 579–
7 863 850)


















1 111 397 
(1 073 601–
1 150 583)
1 289 721 
(1 232 696–
1 350 886)












1 044 178 
(1 009 021–
1 079 083)
1 267 751 
(1 225 483–
1 309 059)
1 512 969 
(1 462 697–
1 561 490)
1 704 731 
(1 638 487–
1 773 613)









1 265 828 
(1 216 449–
1 313 285)
1 551 201 
(1 501 707–
1 605 269)
1 769 031 
(1 711 246–
1 829 574)
1 962 750 
(1 906 995–
2 020 809)
2 090 439 
(1 993 635–
2 188 823)












1 111 992 
(1 075 191–
1 151 041)
1 217 799 
(1 176 410–
1 260 107)
1 319 712 
(1 279 281–
1 364 508)
1 387 317 
(1 310 630–
1 462 683)















1 024 486 
(1 001 540–
1 048 430)
1 098 420 
(1 074 557–
1 122 783)
1 139 825 
(1 098 829–
1 181 331)
Central Europe, eastern 
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1 036 657 
(1 012 835–
1 060 283)
1 074 889 
(1 033 559–
1 116 701)
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Data are thousands of people (95% uncertainty intervals) for all ages and both sexes. Super-regions, regions, and countries are listed alphabetically. Estimates are de-facto population estimates. GBD=Global 
Burden of Diseases, Injuries, and Risk Factors Study. SDI=Socio-demographic Index.
Table 2: The global population and the populations of SDI groups, GBD regions and super-regions, countries, and territories, 1950–2017
high rates of total fertility are associated with high 
rates of population growth in sub-Saharan Africa and 
north Africa and the Middle East. The proportion of 
women whose contraceptive needs are being met 
through the provision of reproductive health services is 
46·5% (95% UI 45·2–47·6) in sub-Saharan Africa and 
69·0% (67·5–70·5) in north Africa and the Middle East.54 
Given that the economic beneﬁts of the demographic 
dividend are estimated to occur when the working-age 
population represents more than 65% of the population,53 
government action to meet the need for family planning 
and to raise the educational attainment of women 
are two potential pathways towards faster economic 
growth. Notably, less than 55% of the population in 
sub-Saharan Africa, on average, are of working age, and 
this proportion is only slowly increasing. Fast economic 
growth in sub-Saharan Africa from 2002 to 2014 shows 
the potential for economic transition in the region; 
capitalising on the demographic dividend might add to 
this potential in the future. Policy options that focus on 
educating young girls, providing access to reproductive 
health services, and continued scale-up of eﬀective 
interventions for child mortality are available to 
accelerate decreases in TFR and demographic change.
By contrast, 33 countries are in overall population 
decline since 2010, including Estonia, Ukraine, Belarus, 
Greece, Georgia, Bulgaria, Romania, and Spain. Many 
other countries are also likely to have decreasing 
populations as the size of their birth cohorts reduces. 
Population decline and the associated shift to an older 
population has profound cultural, economic, and social 
implications. One early measure of this trend is the 
percentage change in the number of livebirths over time; 
in 89 countries, the size of the birth cohort has decreased 
since 2000. The options in these countries to deal with 
the social and economic consequences of population 
decline include pro-natalist policies, liberal immigration 
policies, and increasing the retirement age. Pro-natalist 
policies have been pursued in more than a dozen 
countries but the eﬀects on fertility rates have not been 
large.55–58 Liberal immigration policies have been eﬀective 
in sustaining population numbers in several countries, 
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but such policies have been accom panied by social and 
political challenges in some. Dealing with population 
decline will be a central policy challenge for a substantial 
number of countries over the next few decades. 
In high-income countries, the proportion of the 
population that is of working age has also decreased in 
the past 5 years, and this trend is likely to continue 
for the foreseeable future. This demographic shift toward 
an older population has a broad range of consequences, 
from reductions in economic growth, decreasing tax 
revenue, greater use of social security with fewer 
contributors, and increasing health-care and other 
demands prompted by an ageing population.59–65 This 
shift is advanced in several high-income countries, with 
one of the earliest examples being Japan.66 Our estimates 
show that more than 20% of the population is older than 
65 years in eight countries, implying that the challenges 
of dealing eﬀectively with ageing populations have 
already advanced in these settings. Similarly to overall 
population decline, several policy options have been 
debated and implemented, ranging from immigration, 
increasing retirement ages, pension reform, a focus on 
disease prevention, and investments in human capital, 
such as higher-level skill and knowledge building in a 
shrinking workforce.63,64 In these same regions, the eﬀects 
of decreases in the proportion of the population aged 
15–64 years on economic productivity could be mitigated 
by individuals working far beyond age 65 years. This shift 
to later retirement is already occurring in many countries, 
including the USA, Australia, and Japan.67–72
The fertility rates in children and adolescents aged 
10–19 years is an SDG indicator for goal 3, target 3.7. To 
our knowledge, our analysis provides the ﬁrst annual 
time series of fertility rates in these age groups. Fertility 
rates in ages 15–19 years typically decrease with a 
country’s development but the trends in those aged 
10–14 years are less clear. In addition to the global 
patterns in fertility rates in children and adolescents, 
there are marked variations across countries at similar 
levels of development. Within SDI bands, the ratio of 
highest to lowest adolescent fertility rates is often more 
than an order of magnitude, highlighting that many 
factors other than development status contribute to the 
fertility rate in children and adolescents. Some countries 
have been able to reduce adolescent fertility rates faster 
than expected. A detailed analysis of the determinants of 
the variation in fertility rate among children and 
adolescents across SDI bands, including policy factors, is 
beyond the scope of this study, but this ﬁnding suggests 
that such research is urgently needed.
The population decline that we found in Syria indicates 
the potentially important role of conﬂict on both fertility 
and migration rates. Conﬂict in some settings, such as in 
Kuwait during the ﬁrst Persian Gulf War, can reduce 
fertility rates, but other examples have been found where 
conﬂict has led to younger marriage and increased 
fertility rates.73 We explored adding the death rate from 
conﬂict as a covariate to the fertility estimation model 
but we found that this variable, on average, did not 
predict changes in fertility; this ﬁnding is consistent with 
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Figure 10: Proportion of the population that is of working age, globally and for GBD super-regions, 1950–2017
Working age is defined as 15–64 years. Data are for both sexes combined from 1950 to 2017. GBD= Global Burden of Diseases, Injuries, and Risk Factors Study.
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examples of increases and decreases in fertility in 
individual countries. Conﬂict is also associated with large 
migration ﬂows; many of these are captured in the 
UNHCR migrant stock and derived ﬂow data. Given the 
large-scale migration seen during the conﬂict in Syria, a 
deeper understanding of what determines the magnitude 
of migration before, during, and after conﬂict would be 
useful in planning public health, social, and policy 
interventions to ameliorate the eﬀects of migration on 
individuals and families.
Sex ratios in most countries remain in the narrow band 
of 1·03–1·07 male livebirths for every female livebirth. 
We found in some countries, most notably India and 
China, that since the availability of ultrasonography in the 
early 1980s, the ratio of males to females has increased. In 
China, the sex ratios in 2017 were in excess of 1·16 males 
for every female. These ratios imply very substantial 
sex-selective abortion and even the possibility of female 
infanticide. The eﬀect of such pronounced sex ratios 
on patterns of social interaction might be substantial in 
future gener ations. From the perspective of demographic 
growth, high sex ratios at birth reduce the net reproductive 
rate to below that predicted from the TFR alone. In China, 
low TFR and high sex ratios led to a net reproductive rate 
of 0·69 female livebirths expected per woman.
Cross-cutting themes
An important debate in the medical literature about the 
decreases in fertility has been regarding the relative 
contribution of declines in the under-5 mortality rate, 
women’s educational attainment, and the availability 
of reproductive health services, particularly modern 
contraception methods.74–79 There is a strong correlation 
between estimated TFR and maternal education 
(r=–0·886), the met contraceptive need (r=–0·799), and the 
under-5 mortality rate (r=0·800), which are consistent over 
decades and across SDI quintiles. Nevertheless, use of 
time series of cross-sectional data to estimate causal 
relationships is particularly challenging given that all 
three of these measures are highly correlated. Under-
standing the magnitude of these diﬀerent drivers and their 
complex interconnections is important to understand the 
future trajectory of ASFR. Fertility over the next few 
decades is hard to forecast in regions such as western 
sub-Saharan Africa, where fertility rates remain high, 
progress on educational attainment has been relatively 
modest, met need for contraception remains low (despite 
some recent improvements), and under-5 mortality has 
considerably decreased. Our more detailed time series of 
these drivers could provide opportunities for future studies 
to disentangle the contribution of these diﬀerent factors.
Many factors other than maternal education, repro-
ductive health services, and under-5 mortality rates 
inﬂuence annual fertility rates. The data compiled for 
our study show that there has been marked variation 
in fertility rates annually or over shorter durations in 
response to events with cultural signiﬁcance or policy 
change. For example, the TFR in Singapore increased 
from 2·01 livebirths in 1999 to 2·39 livebirths in 2000, 
whereas in Japan in 1966—the year of the Fire Horse, 
during which giving birth to females was deemed 
unlucky80—the TFR decreased by 13% in a single year. 
Local legislation can also lead to an abrupt increase in the 
TFR: the introduction of a ban on abortion in Romania in 
1966 increased TFR from 2·72 livebirths to 3·53 livebirths 
in the year following the ban. This ban on abortion also 
led to increases in the maternal mortality rate. The recent 
change from the one-child policy in China to a policy 
that allows second births was associated with an 
11·7% increase in total livebirths from 2014 to 2017. 
These abrupt variations in fertility rates highlight the 
importance of understanding the magnitude of policy 
changes on fertility rates, especially in settings where 
fertility rates might have decreased far below the 
replacement value.
Over the past 25 years, annual livebirths globally have 
remained between 133·5 million and 141·7 million 
livebirths per year. This comparative stability has occurred 
even during marked changes in the population of women 
of repro ductive age and highly heterogeneous trends in 
fertility rates. With each year, a larger proportion of the 
birth cohort is represented in regions with lower incomes 
and lower educational attainment because of diﬀerent 
speeds of changing fertility in diﬀerent locations, creating 
a phenomenon known as demographic headwinds.61,64,65 
As more births occur in increasingly diﬃcult circum-
stances, the challenge of meeting the ambitious SDG 
targets will become more diﬃcult. We would expect the 
pace of reductions in the global under-5 mortality rate to 
slow due to the changes in the birth cohort, and similar 
global slowing might be expected for other indicators 
such as childhood vaccination. Other changes, such as 
the slower rates of decrease in neonatal mortality than in 
mortality in post-neonatal infants (age 28–365 days) and 
children aged 1–4 years, might slow the decrease in 
overall child mortality. Evaluating global progress will 
need to take into account these important compositional 
shifts in the global birth cohort in terms of income and 
educational attainment.
Estimation challenges
The biggest challenge in creating population estimates 
that are consistent with observed population counts and 
with data on ASFR and age-speciﬁc mortality is the poor 
data available in many countries regarding net migration. 
We used the GBD Bayesian demographic balancing model 
to eﬀectively infer net migration from the diﬀerence 
between the population expected from fertility and 
mortality rates and that observed in census or registry data. 
For some countries, the model has been informed with 
reported data on documented migration and UNHCR data 
on stocks and ﬂows of refugees. Nevertheless, the only 
data that are increasingly available for many low-income 
and middle-income countries are stocks of migrants 
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reported at the time of the census. Although these data are 
clearly useful, diﬀerent assumptions about mortality rates 
and the timing of migration can lead to very diﬀerent 
estimates of past migration ﬂows, leading to the same 
observed stock of migrants in each country being estimated 
for. Even within these data, some temporary migrants who 
move for employment opportunities might not be 
recorded. More transparent estimates of population with 
standardised methods, such as the methods that we have 
presented, will hopefully drive a more extensive debate on 
data sources for assessing migration and how to improve 
them in the future.
We identiﬁed and extracted results from national PESs 
in only 165 censuses, although it is likely that many more 
have been done but their results have not been publicly 
released. PESs use direct or indirect methods: direct 
PESs match the records of individuals with actual census 
records to estimate census completeness, whereas 
indirect methods ask PES respondents if they participated 
in the census. Direct matching is more reliable but much 
harder to conduct. Censuses and PESs can miss certain 
populations such as homeless people in some countries 
or excluded minorities. The absence of PESs for most 
censuses in most countries means that the actual 
population count in many countries is uncertain. To 
avoid systematic bias, we estimated census completeness 
in all countries. The issue of census completeness 
remains a major challenge and one that cannot easily be 
addressed for past censuses. It is unlikely, for example, 
that we will empirically resolve debates on census 
completeness for many censuses in the 1950s–2000s. 
At best, we can adequately represent this uncertainty in 
our results. Moving forward, standardising the reporting 
of PES results so that some form of systematic analysis 
can be done will aid in future assessments.
Age misreporting, including age heaping, is a sub stantial 
challenge in use of data from many censuses, particularly 
in locations where numeracy of the res pondents is 
relatively low.35,37 In fact, some education research has used 
age heaping as a proxy measure of the quality of 
mathematics education in a country.81 We detected age 
misreporting in many earlier censuses in many countries, 
often manifested by implausible immigration rates 
required to match census counts in the oldest age groups. 
We mitigated the eﬀect of age misreporting by excluding 
some data in the oldest age groups so that the estimates 
are driven by census data at younger age groups and 
mortality estimates, and by increasing the variance of 
population counts at older ages, but this approach does not 
remove all the eﬀects of systematic age misreporting. For 
age heaping, we used the Feeney, Arriaga, and Arriaga 
strong corrections, dependent on the details of age group 
available and the degree of age heaping. These approaches 
have helped to mitigate age misreporting and age-heaping 
issues, but further work on how to analyse these complex 
error patterns in the data will be helpful to improve future 
estimates.
Demographers have long recognised that population 
estimates are necessary for planning, regardless of the 
availability and quality of the data. The challenge for 
demographers is to produce the most plausible estimates 
of population that can be used, rather than simply 
cataloguing all the limitations of the available data or the 
potential for error. This approach was part of the original 
inspiration for GBD. However, demographic estimation 
has also remained quite operator dependent: analytical 
choices by diﬀerent demographers can lead to con-
siderable diﬀerences in estimates for the same country. 
The diﬀerences between UNPOP estimates, US Census 
Bureau estimates, and national government estimates for 
many countries is one illustration of this analyst 
dependence. Demographic estimation has only recently 
started to examine statistical methods that generate 
uncertainty intervals,47–49,82–85 but these have not been 
widely used by UNPOP, the US Census Bureau, or by 
most national authorities for population estimation, and 
these methods remain primarily a research interest. To 
our knowledge, we have generated the ﬁrst complete time 
series of the population size (with uncertainty intervals) 
for all countries by use of such methods; however, there 
are still many analytical choices that have been made that 
could arguably be changed in future eﬀorts. These might 
include the choice of age-heaping smoother, the decision 
to exclude some census counts as outliers, or inclusion of 
documented migration estimates from various sources. 
We hope that this eﬀort will stimulate vigorous debate on 
the analysis of population size for diﬀerent countries.
Limitations
This study has many limitations, some of which—
including the paucity of direct measurement of net 
migration—have already been identiﬁed, whereas others 
need to be articulated. First, the GBD Bayesian demo-
graphic balancing model for population and migration 
estimation includes a number of hyperpriors. The results 
of the estimation are sensitive to the choice of these 
hyperpriors, such as the correlation of migration over 
time. We have largely used the same hyperpriors for all 
locations, but we have modiﬁed the hyperpriors in some 
locations to improve the ﬁt of the model. Second, we 
sought to estimate de-facto population counts, but in 
some low-income and middle-income locations, only de-
jure counts were available as inputs. De-jure counts could, 
in some countries, exclude temporary migrants; we 
identiﬁed and included migration data in locations where 
large labour migration is known to occur, but the use of 
de-jure counts in other settings could overestimate or 
underestimate de-facto counts. Third, we assume that the 
estimates of age-speciﬁc mortality from the GBD study 
and ASFR from this study are accurate. Any systematic 
errors in either would aﬀect our estimates of migration 
and of population in years that are further from a census. 
Fourth, the estimation method requires a baseline 
estimate of the population in 1950 for detailed age groups, 
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and any errors in this baseline based on a backwards 
cohort-component method of population projection will 
have a sustained eﬀect on the population estimates from 
the baseline until at least the ﬁrst census after 1950. Major 
errors in the baseline can also have an eﬀect after the ﬁrst 
census. Fifth, we were unable to obtain census counts by 
sex from ten known censuses and could not obtain age-
speciﬁc population data in 62 censuses. Inclusion of this 
unpublished information could substantially change the 
results for those locations. Sixth, uncertainty in our 
current results is based on the uncertainty in population 
counts and the time since the last population count and, 
implicitly, errors in fertility and mortality estimation. We 
used an out-of-sample approach to estimate uncertainty in 
the population size in years without a census count, and 
we used uncertainty in the PES model prediction of 
completeness to estimate uncertainty in the years with 
and without a census count. The out-of-sample method 
provides a robust approach to estimating uncertainty but 
does not provide draws of migration, fertility, and mortality 
associated with each draw of population. We also assumed 
that years where registry counts are available only have 
uncertainty in the PES model prediction of completeness 
and zero uncertainty from the out-of-sample approach. 
This approach to estimating population uncertainty also 
does not incorporate any spatial correlation of uncertainty 
across countries and assumes complete correlation of 
uncertainty by age. Uncertainty at the country level could 
be exaggerated by this approach. Seventh, age-speciﬁc 
migration estimates can be aﬀected by age-speciﬁc 
variation in census completeness. In our analysis, we have 
included the average age pattern of enumeration 
completeness, as detected in our analysis of PESs, 
but country-speciﬁc variation in the age pattern of 
enumeration is possible. Eighth, refugee ﬂows might be 
misenumerated by UNHCR in some settings, leading to 
underestimates of migrants. Ninth, alternative hyper-
parameters could be selected and could change the results, 
although we believe that our selection of hyperparameters, 
which were based on several rounds of testing, provide 
sensible results. Tenth, we analysed each location 
independently, without imposing global constraints on 
global net migration. As a con sequence, in some years, 
our estimates imply global net migration, which is not 
possible. For example, in 2015, our estimate of global net 
migration was 14 709 people. Finally, our model for fertility 
in girls aged 10–14 years is based on a simple linear 
regression of the ratio of fertility in those aged 10–14 years 
versus those aged 15–19 years, on the fertility rate in those 
aged 15–19 years and 50–54 years was estimated as a ﬁxed 
fraction of the fertility rate in women aged 45–49 years 
because, even in the linear regression, the coeﬃcient was 
not signiﬁcant. This regression is based on locations with 
complete vital registration data, which tend to be high-SDI 
and middle-SDI countries. Other factors might drive 
fertility at these extreme ages that are not captured in our 
models or the available data.
Future directions
There are many ways in which our estimation of population 
by age, sex, location, and year can be improved and made 
more useful for diverse applications. We currently use the 
GBD Bayesian demographic balancing model to estimate 
age-sex-year-speciﬁc migration, consistent with our 
estimated fertility and mortality rates and observed 
population numbers. In settings where direct measure-
ment of migration is possible, it could be useful to use a 
version of the same model that allows the posterior values 
for fertility, mortality, and migration to change relative to 
the prior. This approach is conceptually appealing, 
allowing incon sistencies between fertility, mortality, and 
migration to be resolved through shifts in some or all of 
these inputs. However, our early testing of this approach 
showed considerable instability given that the same 
observed population count can be exactly explained by an 
inﬁnite set of combinations of deaths and migration. This 
instability in the full Bayesian model led to estimates of 
implausible shifts in the age and time pattern of mortality. 
In some settings, it might be possible to provide more 
information on the credible age structure of death and 
migration to stabilise such a version of the model. A second 
improvement in the modelling approach would be to 
address how to ensure that the global net migration in any 
age-sex-year group is zero. Joint estimation of all locations 
simultaneously is unlikely to be computationally feasible 
given the complexity of the model for just one location at a 
time. Two-stage processes can be explored that might 
accommodate the logical requirement for global net 
migration to be zero. Another avenue that warrants 
investigation is the inclusion in the analysis of household 
age structure from household surveys; there is a very wide 
array of these surveys, and methods to use this information 
with appropriately wider data variance than a census could 
improve estimation in census-poor locations. We currently 
adjust data for age heaping with the three correction 
methods (Feeney, Arriaga, and Arriaga strong), but there 
could be other ways to incorporate age-heaping corrections 
directly into the GBD Bayesian demographic balancing 
model likelihood. In future analyses of fertility and 
population, the im portant role of urbanisation should be 
explored. Given the drive in many GBD-related analyses 
toward 5 × 5 km estimation,86,87 the logical extension of our 
analysis will be to generate population estimates at a 
detailed local level. Such eﬀorts will need to leverage 
similarly ﬁne-grained assessments of fertility, mortality, 
and available population counts, supplemented with 
satellite imagery where feasible.
Conclusion
Population size and age structure have substantial 
consequences on every aspect of social and economic life 
in every location. Over the past 70 years, there have 
been huge changes in ASFR, mortality, and migration 
that have reshaped popu lation structures. Trends have 
not been homogeneous across and within countries and, 
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although global population growth rates have decreased, 
the absolute increase in global population every year 
has remained notably constant for many decades. 
Linear growth in the global population is occurring 
despite population decreases in some parts of the world, 
particularly eastern Europe, and large population 
increases in sub-Saharan Africa. Demographic changes 
will continue to have substantial social and economic 
eﬀects, highlighting the impor tance of close monitoring 
and analysis of fertility and population at the local level. 
The statistical methods for estimation that we present 
will hopefully facilitate this need, providing the essential 
demographic intelligence for countries to reliably inform 
their health and social development strategies.
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Paediatrics (M T Mackay PhD, Prof G C Patton MD), School of Health 
Sciences (A Meretoja MD, Prof C E I Szoeke PhD), School of Population 
and Global Health (M M Hosseini Chavoshi PhD), University of 
Melbourne, Melbourne, VIC, Australia (Prof A D Lopez PhD); 
Department of Computer Science (M Hosseinzadeh PhD), University of 
Human Development, Sulaimaniyah, Iraq; Department of Internal 
Medicine (M Hostiuc PhD), Bucharest Emergency Hospital, Bucharest, 
Romania; Clinical Legal Medicine (S Hostiuc PhD), National Institute of 
Legal Medicine Mina Minovici, Bucharest, Romania; Faculty of Medicine 
Tunis (Prof M Hsairi MPH), Medicine School of Tunis, Baab Saadoun, 
Tunisia; Department of Epidemiology and Health Statistics 
(Prof G Hu PhD), Central South University, Changsha, China; 
Department of Public Health (K M Iburg PhD), National Centre for 
Register-based Research (Prof J J McGrath MD), Aarhus University, 
Aarhus, Denmark; School of Public Health (Prof E U Igumbor PhD), 
University of the Western Cape, Bellville, Cape Town, South Africa; 
Department of Public Health (Prof E U Igumbor PhD), Walter Sisulu 
University, Mthatha, South Africa; Department of Public Health and 
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(Prof U Iqbal PhD), Graduate Institute of Biomedical Informatics 
(D N A Ningrum MPH), Taipei Medical University, Taipei City, Taiwan, 
Taiwan; School of Public Health (O O Isehunwa MD), University of 
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Sciences (M A Malik MPhil), Indian Institute of Technology, Roorkee, 
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Department of Health Policy (Prof R Mori PhD), National Center for 
Child Health and Development, Setagaya, Japan; Department of Clinical 
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(J Nansseu MD), University of Yaoundé I, Yaoundé, Cameroon; Mercy 
Saint Vincent Medical Center, Toledo, OH, USA (H Nawaz MD); 
Department of Cardiology (R I Negoi PhD), Cardio-Aid, Bucharest, 
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Research (S Nomura MSc), National Center for Global Health and 
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Rio de Janeiro, Brazil; Cartagena University, Cartagena, Colombia 
(Prof D M Pereira PhD); Independent Consultant, Glenelg, SA, Australia 
(Prof K Pesudovs PhD); Anesthesiology Department (A S Terkawi MD), 
School of Medicine (W A Petri MD), University of Virginia, 
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